Skip to main content
. 2017 Nov 21;7(1):11–19. doi: 10.1002/sctm.17-0139

Table 2.

Adverse events of MSC patients

Subject ID AE Description Start Date End Date Severity Casual Relationship Action Taken SAE? SAE Reason Outcome
MSC1 None
MSC2 Dehydration 4/1/15 4/13/15 1 1 2 Y 2 1
MSC2 Portal vein thrombosis 4/22/15 1 1 2 Y 6 1
MSC2 Pneumonia 4/29/15 5/1/15 1 1 2 Y 2 1
MSC2 Pleural effusion 6/20/15 6/26/15 1 1 1 Y 2 1
MSC2 Latent TB infection w/fever 7/15/15 7/26/15 1 1 1 Y 2 1
MSC2 Right pleural effusion 8/19/15 8/20/15 1 1 1 Y 2 1
MSC3 Left portal vein thrombosis 6/1/15 6/20/15 1 1 2 Y 6 1
MSC3 Emesis 6/11/15 6/18/15 1 1 2 Y 2 1
MSC3 Upper GI bleed 6/11/15 6/18/15 3 1 3 Y 2 1
Key
Severity Casual Relationship Action Taken SAE Reason Outcome
Grade 1 = Mild 1 = None 1 = Life‐ threatening 1 = Recovered
Grade 2 = Moderate 1 = Unlikely 2 = Medication 2 = Required hospitalization 2 = Ongoing
Grade 3 = Severe 2 = Possibly 3 = Other 3 = Prolonging existing hospitalization 3 = Recovered with sequela
Grade 4 = Life‐ threatening 3 = Probably 4 = Resulting in persistent significant disability or incapacity 4 = Fatal
Grade 5 = Death 5 = Congenital anomaly or birth defect 5 = Unknown
6 = Medically significant or important medical condition
7 = Death

Abbreviations: AE, adverse event; GI, gastrointestinal; MSC, mesenchymal stem cell; SAE, serious adverse events; TB, tuberculosis; Y, yes.